Vivimed Labs (Alathur) Profile
Key Indicators
- Authorised Capital ₹ 70.00 Cr
as on 20-04-2024
- Paid Up Capital ₹ 50.17 Cr
as on 20-04-2024
- Company Age 18 Year, 28 Days
- Last Filing with ROC 31 Mar 2016
- Satisfied Charges ₹ 53.50 Cr
as on 20-04-2024
- Revenue -70.44%
(FY 2015)
- Profit 45.21%
(FY 2015)
- Ebitda -667.07%
(FY 2015)
- Net Worth -5.67%
(FY 2015)
- Total Assets -3.62%
(FY 2015)
About Vivimed Labs (Alathur)
- CIN/LLPIN
U24219MH2006PTC165760
- Company No.
165760
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2006
- Date of AGM
26 Sep 2015
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vivimed Labs (Alathur)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Varalwar  | Director | 31-Jul-2013 | Current |
| Manohar Varalwar | Additional Director | 31-Jul-2013 | Current |
| Sandeep Varalwar | Director | 31-Jul-2013 | Current |
Financial Performance and Corporate Structure Insights of Vivimed Labs (Alathur).
Vivimed Labs (Alathur) Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 70.44% decrease. The company also saw a substantial improvement in profitability, with a 45.21% increase in profit. The company's net worth dipped by a decrease of 5.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivimed Labs (Alathur)?
In 2016, Vivimed Labs (Alathur) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vivimed Labs LimitedActive 36 years 2 monthsSantosh Varalwar, Manohar Varalwar and 1 more are mutual person
B B R Projects Private LimitedActive 19 years 11 monthsSantosh Varalwar, Manohar Varalwar and 1 more are mutual person
- Kreative Hosts Atria Private LimitedActive 17 years 8 days
Santosh Varalwar and Manohar Varalwar are mutual person
- Atri Pharma Research (India) Private LimitedActive 15 years 10 months
Santosh Varalwar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tamilnadu Industrial Investment Corporation Limited Creation Date: 31 Mar 2010 | ₹20.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 15 Nov 2007 | ₹12.50 Cr | Satisfied |
Idbi Bank Creation Date: 23 Oct 2007 | ₹21.00 Cr | Satisfied |
How Many Employees Work at Vivimed Labs (Alathur)?
Unlock and access historical data on people associated with Vivimed Labs (Alathur), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivimed Labs (Alathur), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivimed Labs (Alathur)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
